MedPath

Case Management Study to Reduce Health Care Utilization for Frequent Hospital Care Users

Not Applicable
Conditions
Quality of Life
Interventions
Behavioral: Interview followed by frequent telephone support
Registration Number
NCT02583555
Lead Sponsor
Region Sjælland
Brief Summary

The purpose of this study is to identify persons with high risk of frequent hospital admissions and by counselling by one in depth interview followed by frequent telephone contacts improve their quality of life and reduce their healthcare utilization.

Detailed Description

Participants are identified by administrative data and a model predicting high risk of future healthcare utilization. Participants are invited to the study by mail. After informed consent participants are randomized to either active treatment or control 3:1. Active patients have an in depth interview with a specially trained nurse. Further counselling by telephone weekly for 6-9 months.

Quality of Life is measured by SF-36 every 3 months for one year both in active participants and in controls.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Patient > 18 years
  • Recent history of contact with hospital
  • Anticipated sustained high visit frequency
Exclusion Criteria
  • Dementia (ICD10: F00-F03 or F051)
  • Psychoses (ICD10: F20-F29)
  • Drug abuse (ICD10: F10-F19)
  • Metastases (ICD10: C77-C80)
  • Hearing impairment or language difficulties
  • Life expectancy < 1 year No telephone

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active patient supportInterview followed by frequent telephone supportInterview followed by frequent telephone support Questionnaire every 3 months
Primary Outcome Measures
NameTimeMethod
Health Care Utilization - Admissions to and days in hospitalOne year

The use of different health care systems will be recorded

Quality of Life reported by the participants with use of Short Form 36Questionaire Short Form-36 Every 3 months for one year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Regional Research

🇩🇰

Roskilde, Denmark

© Copyright 2025. All Rights Reserved by MedPath